As of Apr 20
| -0.15 / -0.78%|
The 6 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 32.50, with a high estimate of 39.00 and a low estimate of 8.00. The median estimate represents a +70.60% increase from the last price of 19.05.
The current consensus among 7 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.